Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 727 | 650 | 3,510 | 8,714 | 9,343 |
| Gross Profit | 727 | 650 | 3,510 | 8,714 | 9,343 |
| Operating Expenses | 16,647 | 15,684 | 17,323 | 18,964 | 15,057 |
| Operating Income | -15,920 | -15,034 | -13,813 | -10,250 | -5,714 |
| Other Income | 314 | 150 | 615 | -479 | 195 |
| Pre-tax Income | -15,606 | -14,884 | -13,199 | -10,730 | -5,520 |
| Net Income Continuous | -15,606 | -14,884 | -13,199 | -10,732 | -5,520 |
| Net Income | $-15,606 | $-14,884 | $-13,199 | $-10,732 | $-5,520 |
| EPS Basic Total Ops | -0.18 | -0.18 | -0.18 | -0.15 | -0.07 |
| EPS Basic Continuous Ops | -0.18 | -0.18 | -0.18 | -0.14 | -0.07 |
| EPS Diluted Total Ops | -0.18 | -0.18 | -0.18 | -0.15 | -0.07 |
| EPS Diluted Continuous Ops | -0.18 | -0.18 | -0.18 | -0.14 | -0.07 |
| EBITDA(a) | $-14,507 | $-13,642 | $-12,564 | $-8,999 | $-4,627 |